AAAAAA

   
Results: 1-20 |
Results: 20
IN-VITRO P24 ANTIGEN-STIMULATED LYMPHOCYTE-PROLIFERATION AND BETA-CHEMOKINE PRODUCTION IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1)-SEROPOSITIVE SUBJECTS AFTER IMMUNIZATION WITH AN INACTIVATED GP120-DEPLETEDHIV-1 IMMUNOGEN (REMUNE)
Authors: MOSS RB WALLACE MR LANZA P GIERMAKOWSKA W JENSEN FC THEOFAN G CHAMBERLIN C RICHIERI SP CARLO DJ
Citation: Rb. Moss et al., IN-VITRO P24 ANTIGEN-STIMULATED LYMPHOCYTE-PROLIFERATION AND BETA-CHEMOKINE PRODUCTION IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1)-SEROPOSITIVE SUBJECTS AFTER IMMUNIZATION WITH AN INACTIVATED GP120-DEPLETEDHIV-1 IMMUNOGEN (REMUNE), Clinical and diagnostic laboratory immunology, 5(3), 1998, pp. 308-312
A PRIMER ON HIV TYPE 1-SPECIFIC IMMUNE FUNCTION AND REMUNE(TM)
Authors: MOSS RB GIERMAKOWSKA WK SAVARY JR THEOFAN G DAIGLE AE RICHIERI SP JENSEN FC CARLO DJ
Citation: Rb. Moss et al., A PRIMER ON HIV TYPE 1-SPECIFIC IMMUNE FUNCTION AND REMUNE(TM), AIDS research and human retroviruses, 14, 1998, pp. 167-175
EFFECT OF HIV-SPECIFIC IMMUNE-BASED THERAPY IN SUBJECTS INFECTED WITHHIV-1 SUBTYPE-E IN THAILAND
Authors: CHURDBOONCHART V MOSS RB SIRAWARAPORN W SMUTHARAKS B SUTTHENT R JENSEN FC VACHARAK P GRIMES J THEOFAN G CARLO DJ
Citation: V. Churdboonchart et al., EFFECT OF HIV-SPECIFIC IMMUNE-BASED THERAPY IN SUBJECTS INFECTED WITHHIV-1 SUBTYPE-E IN THAILAND, AIDS, 12(12), 1998, pp. 1521-1527
WHOLE-KILLED GP120-DEPLETED HIV-1 ANTIGEN IN A MURINE MODEL FOR PROPHYLACTIC VACCINATION
Authors: LANZA P MOSS RB GIERMAKOWSKA W HANCOCK RB RICHIERI SP THEOFA G JENSEN FC SALK PL CARLO DJ
Citation: P. Lanza et al., WHOLE-KILLED GP120-DEPLETED HIV-1 ANTIGEN IN A MURINE MODEL FOR PROPHYLACTIC VACCINATION, Vaccine, 16(7), 1998, pp. 727-731
ADJUVANT ACTIVITY OF INCOMPLETE FREUNDS-ADJUVANT
Authors: CHANG JCC DIVELEY JP SAVARY JR JENSEN FC
Citation: Jcc. Chang et al., ADJUVANT ACTIVITY OF INCOMPLETE FREUNDS-ADJUVANT, Advanced drug delivery reviews, 32(3), 1998, pp. 173-186
EFFECT OF IMMUNIZATION WITH AN INACTIVATED GP120-DEPLETED HIV-1 IMMUNOGEN ON BETA-CHEMOKINE AND CYTOKINE PRODUCTION IN SUBJECTS WITH HIV-1 INFECTION
Authors: MOSS RB TRAUGER RJ GIERMAKOWSKA WK TURNER JL WALLACE MR JENSEN FC RICHIERI SP FERRE F DAIGLE AE DUFFY C THEOFAN G CARLO DJ
Citation: Rb. Moss et al., EFFECT OF IMMUNIZATION WITH AN INACTIVATED GP120-DEPLETED HIV-1 IMMUNOGEN ON BETA-CHEMOKINE AND CYTOKINE PRODUCTION IN SUBJECTS WITH HIV-1 INFECTION, Journal of acquired immune deficiency syndromes and human retrovirology, 14(4), 1997, pp. 343-350
HIV-1-SPECIFIC FUNCTIONAL IMMUNE MEASUREMENTS AS MARKERS OF DISEASE PROGRESSION
Authors: MOSS RB RICHIERI SP FERRE F DAIGLE AE TRAUGER R THEOFAN G GIERMAKOWSKA W LANZA P BROSTOFF S CARLO DJ JENSEN FC
Citation: Rb. Moss et al., HIV-1-SPECIFIC FUNCTIONAL IMMUNE MEASUREMENTS AS MARKERS OF DISEASE PROGRESSION, Journal of biomedical science, 4(4), 1997, pp. 127-131
HIV TYPE-1 ISOLATE Z321, THE STRAIN USED TO MAKE A THERAPEUTIC HIV TYPE-1 IMMUNOGEN, IS INTERSUBTYPE RECOMBINANT
Authors: CHOI DJ DUBE S SPICER TP SLADE HB JENSEN FC POIESZ BJ
Citation: Dj. Choi et al., HIV TYPE-1 ISOLATE Z321, THE STRAIN USED TO MAKE A THERAPEUTIC HIV TYPE-1 IMMUNOGEN, IS INTERSUBTYPE RECOMBINANT, AIDS research and human retroviruses, 13(4), 1997, pp. 357-361
CROSS-CLADE IMMUNE-RESPONSES AFTER IMMUNIZATION WITH A WHOLE-KILLED GP120-DEPLETED HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 IMMUNOGEN IN INCOMPLETE FREUNDS-ADJUVANT (HIV-1 IMMUNOGEN, REMUNE(TM)) IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 SEROPOSITIVE SUBJECTS
Authors: MOSS RB GIERMAKOWSKA W LANZA P TURNER JL WALLACE MR JENSEN FC THEOFAN G RICHIERI SP CARLO DJ
Citation: Rb. Moss et al., CROSS-CLADE IMMUNE-RESPONSES AFTER IMMUNIZATION WITH A WHOLE-KILLED GP120-DEPLETED HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 IMMUNOGEN IN INCOMPLETE FREUNDS-ADJUVANT (HIV-1 IMMUNOGEN, REMUNE(TM)) IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 SEROPOSITIVE SUBJECTS, Viral immunology, 10(4), 1997, pp. 221-228
EFFECT OF IMMUNIZATION WITH AN INACTIVATED GP120 DEPLETED HIV-1 IMMUNOGEN (REMUNE(TM) ON BETA-CHEMOKINE AND CYTOKINE PRODUCTION IN SUBJECTSWITH HIV-1 INFECTION
Authors: MOSS RB TRAUGER RJ GIERMAKOWSKA WK TURNER JL WALLACE MR RICHIERI SP FERRE F DAIGLE AE DUFFY C THEOFAN G CARLO DJ JENSEN FC
Citation: Rb. Moss et al., EFFECT OF IMMUNIZATION WITH AN INACTIVATED GP120 DEPLETED HIV-1 IMMUNOGEN (REMUNE(TM) ON BETA-CHEMOKINE AND CYTOKINE PRODUCTION IN SUBJECTSWITH HIV-1 INFECTION, Journal of allergy and clinical immunology, 99(1), 1997, pp. 193-193
INITIAL STUDIES ON ACTIVE IMMUNIZATION OF HIV-INFECTED SUBJECTS USINGA GP120-DEPLETED HIV-1 IMMUNOGEN - LONG-TERM FOLLOW-UP
Authors: LEVINE AM GROSHEN S ALLEN J MUNSON KM CARLO TJ DAIGLE AE FERRE F JENSEN FC RICHIERI SP TRAUGER RJ PARKER JW SALK PL SALK J
Citation: Am. Levine et al., INITIAL STUDIES ON ACTIVE IMMUNIZATION OF HIV-INFECTED SUBJECTS USINGA GP120-DEPLETED HIV-1 IMMUNOGEN - LONG-TERM FOLLOW-UP, Journal of acquired immune deficiency syndromes and human retrovirology, 11(4), 1996, pp. 351-364
COMBINATION THERAPIES AGAINST HIV-1 INFECTION - EXPLORING THE CONCEPTOF COMBINING ANTIRETROVIRAL DRUG TREATMENTS WITH HIV-1 IMMUNE-BASED THERAPIES IN ASYMPTOMATIC INDIVIDUALS
Authors: FERRE F MOSS RB DAIGLE AE TRAUGER RJ RICHIERI SP JENSEN FC CARLO DJ
Citation: F. Ferre et al., COMBINATION THERAPIES AGAINST HIV-1 INFECTION - EXPLORING THE CONCEPTOF COMBINING ANTIRETROVIRAL DRUG TREATMENTS WITH HIV-1 IMMUNE-BASED THERAPIES IN ASYMPTOMATIC INDIVIDUALS, AIDS patient care, 10(6), 1996, pp. 357-361
VIRAL LOAD, CD4 PERCENTAGE, AND DELAYED-TYPE HYPERSENSITIVITY IN SUBJECTS RECEIVING THE HIV-1 IMMUNOGEN AND ANTIVIRAL DRUG-THERAPY
Authors: MOSS RB FERRE F LEVINE A TURNER J JENSEN FC DAIGLE AE RICHIERI SP TRUCKENBROD A TRAUGER RJ CARLO DJ SALK J
Citation: Rb. Moss et al., VIRAL LOAD, CD4 PERCENTAGE, AND DELAYED-TYPE HYPERSENSITIVITY IN SUBJECTS RECEIVING THE HIV-1 IMMUNOGEN AND ANTIVIRAL DRUG-THERAPY, Journal of clinical immunology, 16(5), 1996, pp. 266-271
AUTOPROLIFERATION IN HIV-1-INFECTED PATIENTS UNDERGOING ACTIVE HIV-1-SPECIFIC IMMUNOTHERAPY
Authors: TRAUGER RJ GIERMAKOWSKA W WORMSLEY S TURNER J JENSEN FC CARLO DJ
Citation: Rj. Trauger et al., AUTOPROLIFERATION IN HIV-1-INFECTED PATIENTS UNDERGOING ACTIVE HIV-1-SPECIFIC IMMUNOTHERAPY, Clinical and experimental immunology, 100(1), 1995, pp. 7-12
EFFECT OF THERAPEUTIC VACCINATION ON VIRAL BURDEN IN ASYMPTOMATIC INDIVIDUALS AS DETERMINED BY A QUANTITATIVE PCR-DNA ASSAY
Authors: FERRE F TIPPING D DAIGLE A RICHIERI SP JENSEN FC CARLO DJ SALK J
Citation: F. Ferre et al., EFFECT OF THERAPEUTIC VACCINATION ON VIRAL BURDEN IN ASYMPTOMATIC INDIVIDUALS AS DETERMINED BY A QUANTITATIVE PCR-DNA ASSAY, AIDS research and human retroviruses, 10, 1994, pp. 190000159-190000159
EFFECT OF IMMUNIZATION WITH INACTIVATED GP120-DEPLETED HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) IMMUNOGEN ON HIV-1 IMMUNITY, VIRAL-DNA, AND PERCENTAGE OF CD4 CELLS
Authors: TRAUGER RJ FERRE F DAIGLE AE JENSEN FC MOSS RB MUELLER SH RICHIERI SP SLADE HB CARLO DJ
Citation: Rj. Trauger et al., EFFECT OF IMMUNIZATION WITH INACTIVATED GP120-DEPLETED HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) IMMUNOGEN ON HIV-1 IMMUNITY, VIRAL-DNA, AND PERCENTAGE OF CD4 CELLS, The Journal of infectious diseases, 169(6), 1994, pp. 1256-1264
DEVELOPMENT AND VALIDATION OF QUANTITATIVE PCR ASSAYS TO ACCURATELY ASSESS THE AMOUNT OF HIV-1 DNA RNA IN BLOOD-CELLS FROM PATIENTS UNDERGOING A ONE-YEAR IMMUNOTHERAPEUTIC TREATMENT
Authors: FERRE F MARCHESE A PEZZOLI P GRIFFIN SL JENSEN FC CARLO DJ
Citation: F. Ferre et al., DEVELOPMENT AND VALIDATION OF QUANTITATIVE PCR ASSAYS TO ACCURATELY ASSESS THE AMOUNT OF HIV-1 DNA RNA IN BLOOD-CELLS FROM PATIENTS UNDERGOING A ONE-YEAR IMMUNOTHERAPEUTIC TREATMENT, Journal of acquired immune deficiency syndromes, 6(6), 1993, pp. 728-728
DEVELOPMENT AND VALIDATION OF A POLYMERASE CHAIN-REACTION METHOD FOR THE PRECISE QUANTITATION OF HIV-1 DNA IN BLOOD-CELLS FROM SUBJECTS UNDERGOING A 1-YEAR IMMUNOTHERAPEUTIC TREATMENT
Authors: FERRE F MARCHESE AL GRIFFIN SL DAIGLE AE RICHIERI SP JENSEN FC CARLO DJ
Citation: F. Ferre et al., DEVELOPMENT AND VALIDATION OF A POLYMERASE CHAIN-REACTION METHOD FOR THE PRECISE QUANTITATION OF HIV-1 DNA IN BLOOD-CELLS FROM SUBJECTS UNDERGOING A 1-YEAR IMMUNOTHERAPEUTIC TREATMENT, AIDS, 7, 1993, pp. 190000021-190000027
LIPID-COMPOSITION AND FLUIDITY OF THE HUMAN-IMMUNODEFICIENCY-VIRUS ENVELOPE AND HOST-CELL PLASMA-MEMBRANES
Authors: ALOIA RC TIAN HR JENSEN FC
Citation: Rc. Aloia et al., LIPID-COMPOSITION AND FLUIDITY OF THE HUMAN-IMMUNODEFICIENCY-VIRUS ENVELOPE AND HOST-CELL PLASMA-MEMBRANES, Proceedings of the National Academy of Sciences of the United Statesof America, 90(11), 1993, pp. 5181-5185
T-CELL RECEPTOR V-BETA REPERTOIRE IN HIV-INFECTED INDIVIDUALS - LACK OF EVIDENCE FOR SELECTIVE V-BETA DELETION
Authors: BOYER V SMITH LR FERRE F PEZZOLI P TRAUGER RJ JENSEN FC CARLO DJ
Citation: V. Boyer et al., T-CELL RECEPTOR V-BETA REPERTOIRE IN HIV-INFECTED INDIVIDUALS - LACK OF EVIDENCE FOR SELECTIVE V-BETA DELETION, Clinical and experimental immunology, 92(3), 1993, pp. 437-441
Risultati: 1-20 |